Atrium Therapeutics
RNA
#4304
Rank
HK$19.08 B
Marketcap
HK$121.04
Share price
-6.47%
Change (1 day)
-51.43%
Change (1 year)

Atrium Therapeutics (RNA) Fails to deliver data

Key failure to deliver metrics for Atrium Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atrium Therapeutics (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atrium Therapeutics (RNA) - since 2020

Volume in USD (price x number of shares), data since 2020

Atrium Therapeutics (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$0.92 M-98.13%
2025HK$49.36 M206.29%
2024HK$16.11 M267.16%
2023HK$4.38 M-91.34%
2022HK$50.7 M162.44%
2021HK$19.31 M-77.68%
2020HK$86.53 M